The VDAC1-based peptide, Retro-Tf-D-LP4, acts to interfere with the action of anti-apoptotic proteins overexpressed in cancer and to confer chemoresistance to apoptosis-inducing drugs [25]. This evidence concerns the gene TF and cancer.